España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Kurt Schmidt
These 7 Cannabis Stocks May Be Underappreciated As Market Continues To Rebound
Cronos Group's Mike Gorenstein Returns As CEO
Cronos Group Reports 59% YoY Revenue Increase In FY 2021, Plans To Exit Of Peace Naturals Campus In Stayner, ON
Cronos Group's Mike Gorenstein Returns As CEO
Cronos Group Reports 59% YoY Revenue Increase In FY 2021, Plans To Exit Of Peace Naturals Campus In Stayner, ON
Cronos Q3 Revenue Grows 79% YoY To $20.4M, Audit Committee Completes Evaluation
Cannabis Movers & Shakers: Acreage, MedMen, Halo Collective, Fire & Flower, Cronos Group, Perfect Union
Cronos Q3 Revenue Grows 79% YoY To $20.4M, Audit Committee Completes Evaluation
Cannabis Movers & Shakers: Acreage, MedMen, Halo Collective, Fire & Flower, Cronos Group, Perfect Union
Cronos Group CBD Co. Shares Slightly Down After Announcing Q2 2021 Results And New CFO Appointment
Cannabis Movers & Shakers: Akerna, Jushi, Glass House, Papa & Barkley, Media Central Corp, Santa Fe Farms, Cronos Group
Read More...
Kurt Schmidt Recent News
Cronos Group Shares Slightly Up After Announcing Purchase Of 10.5% Stake In PharmaCann For $110.4M
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is poised to acquire a stake in PharmaCann for approximately $110.4 million.
Cronos Group, Ginkgo Bioworks Modify Agreement To Speed Up Commercialization of Cultured Cannabinoids
Cannabinoid company Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is amending its previous partnership agreement with Ginkgo Bioworks, Inc., a company involved in cell programming.
Cronos Group Encourages Responsibility In Cannabis Industry, Introduces Marketing Code
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) released a Marketing Code addressing the issue of targeting young people who are below the legal age for adult-use cannabis consumption.
Cronos Group Posts Earnings Report, Rolls Out 'Happy Dance' At ULTA Beauty Stores
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) released Friday its fourth quarter and full-year 2020 financial results with a yearly net loss of $75 million, compared to a net income of $1.1 million in 2019.
Cannabis Movers & Shakers: Champions + Legends, Proven Media, Bluma, Schwazze, Cronos, Lantern
Here are the latest corporate shake-ups in the cannabis industry: Jay Glazer Announced Champions + Legends' Founding Partner American sportswriter Jason Charles "Jay" Glazer was declared Champions + Legends' founding partner.
Why Blue Buffalo Is Soaring